| Literature DB >> 31734322 |
Pernille Høgh Danielsen1, Kristina Bram Knudsen1, Janez Štrancar2, Polona Umek2, Tilen Koklič2, Maja Garvas2, Esa Vanhala3, Sauli Savukoski3, Yaobo Ding4, Anne Mette Madsen1, Nicklas Raun Jacobsen1, Ingrid Konow Weydahl1, Trine Berthing1, Sarah Søs Poulsen1, Otmar Schmid4, Henrik Wolff5, Ulla Vogel6.
Abstract
Nanomaterial (NM) characteristics may affect the pulmonary toxicity and inflammatory response, including specific surface area, size, shape, crystal phase or other surface characteristics. Grouping of TiO2 in hazard assessment might be challenging because of variation in physicochemical properties. We exposed C57BL/6 J mice to a single dose of four anatase TiO2 NMs with various sizes and shapes by intratracheal instillation and assessed the pulmonary toxicity 1, 3, 28, 90 or 180 days post-exposure. The quartz DQ12 was included as benchmark particle. Pulmonary responses were evaluated by histopathology, electron microscopy, bronchoalveolar lavage (BAL) fluid cell composition and acute phase response. Genotoxicity was evaluated by DNA strand break levels in BAL cells, lung and liver in the comet assay. Multiple regression analyses were applied to identify specific TiO2 NMs properties important for the pulmonary inflammation and acute phase response. The TiO2 NMs induced similar inflammatory responses when surface area was used as dose metrics, although inflammatory and acute phase response was greatest and more persistent for the TiO2 tube. Similar histopathological changes were observed for the TiO2 tube and DQ12 including pulmonary alveolar proteinosis indicating profound effects related to the tube shape. Comparison with previously published data on rutile TiO2 NMs indicated that rutile TiO2 NMs were more inflammogenic in terms of neutrophil influx than anatase TiO2 NMs when normalized to total deposited surface area. Overall, the results suggest that specific surface area, crystal phase and shape of TiO2 NMs are important predictors for the observed pulmonary effects of TiO2 NMs.Entities:
Keywords: Acute phase response; Crystal phase; Inflammation; Nanoparticles; Pulmonary alveolar proteinosis; Titanium dioxide
Year: 2019 PMID: 31734322 DOI: 10.1016/j.taap.2019.114830
Source DB: PubMed Journal: Toxicol Appl Pharmacol ISSN: 0041-008X Impact factor: 4.219